Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities... Show more
The Moving Average Convergence Divergence (MACD) for BAK turned positive on March 17, 2025. Looking at past instances where BAK's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BAK's RSI Indicator exited the oversold zone, of 41 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where BAK advanced for three days, in of 271 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 51 cases where BAK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BAK as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
BAK moved below its 50-day moving average on February 25, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for BAK crossed bearishly below the 50-day moving average on March 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
BAK broke above its upper Bollinger Band on March 26, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for BAK entered a downward trend on March 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.100) is normal, around the industry mean (3.647). P/E Ratio (7.446) is within average values for comparable stocks, (34.248). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.088). BAK's Dividend Yield (0.311) is considerably higher than the industry average of (0.038). P/S Ratio (0.283) is also within normal values, averaging (94.064).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BAK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 81, placing this stock worse than average.
a manufacturer of petrochemicals and other related products
Industry ChemicalsSpecialty
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
REGL | 81.64 | 0.64 | +0.79% |
ProShares S&P MidCap 400 Dividend Arst | |||
QYLE | 26.92 | N/A | N/A |
Global X Nasdaq 100 ESG Covered Call ETF | |||
VKI | 8.63 | -0.01 | -0.12% |
Invesco Advantage Municipal Income Trust II | |||
HAP | 49.90 | -0.08 | -0.16% |
VanEck Natural Resources ETF | |||
CUBA | 2.64 | -0.06 | -2.22% |
Herzfeld Caribbean Basin Fund |
A.I.dvisor indicates that over the last year, BAK has been loosely correlated with SCL. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BAK jumps, then SCL could also see price increases.
Ticker / NAME | Correlation To BAK | 1D Price Change % | ||
---|---|---|---|---|
BAK | 100% | -0.27% | ||
SCL - BAK | 35% Loosely correlated | +0.66% | ||
TSE - BAK | 31% Poorly correlated | +2.91% | ||
AVNT - BAK | 31% Poorly correlated | +2.68% | ||
BASFY - BAK | 31% Poorly correlated | -0.32% | ||
WLK - BAK | 31% Poorly correlated | +2.03% | ||
More |